Structure

Physi-Chem Properties

Molecular Weight:  316.09
Volume:  311.205
LogP:  2.034
LogD:  2.483
LogS:  -3.183
# Rotatable Bonds:  3
TPSA:  96.22
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.797
Synthetic Accessibility Score:  3.119
Fsp3:  0.235
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.801
MDCK Permeability:  1.1981816896877717e-05
Pgp-inhibitor:  0.008
Pgp-substrate:  0.214
Human Intestinal Absorption (HIA):  0.017
20% Bioavailability (F20%):  0.791
30% Bioavailability (F30%):  0.86

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.062
Plasma Protein Binding (PPB):  95.94721221923828%
Volume Distribution (VD):  0.586
Pgp-substrate:  2.981557607650757%

ADMET: Metabolism

CYP1A2-inhibitor:  0.916
CYP1A2-substrate:  0.702
CYP2C19-inhibitor:  0.771
CYP2C19-substrate:  0.112
CYP2C9-inhibitor:  0.754
CYP2C9-substrate:  0.931
CYP2D6-inhibitor:  0.676
CYP2D6-substrate:  0.894
CYP3A4-inhibitor:  0.846
CYP3A4-substrate:  0.59

ADMET: Excretion

Clearance (CL):  12.757
Half-life (T1/2):  0.866

ADMET: Toxicity

hERG Blockers:  0.066
Human Hepatotoxicity (H-HT):  0.133
Drug-inuced Liver Injury (DILI):  0.338
AMES Toxicity:  0.695
Rat Oral Acute Toxicity:  0.118
Maximum Recommended Daily Dose:  0.218
Skin Sensitization:  0.56
Carcinogencity:  0.412
Eye Corrosion:  0.003
Eye Irritation:  0.318
Respiratory Toxicity:  0.032

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC67876

Natural Product ID:  NPC67876
Common Name*:   Caesalpiniaphenol A
IUPAC Name:   (3R)-3,7-dihydroxy-3-[(4-hydroxy-3-methoxyphenyl)methyl]-2H-chromen-4-one
Synonyms:   Caesalpiniaphenol A
Standard InCHIKey:  IZXFOZCITJGROS-QGZVFWFLSA-N
Standard InCHI:  InChI=1S/C17H16O6/c1-22-15-6-10(2-5-13(15)19)8-17(21)9-23-14-7-11(18)3-4-12(14)16(17)20/h2-7,18-19,21H,8-9H2,1H3/t17-/m1/s1
SMILES:  COc1cc(ccc1O)C[C@@]1(O)COc2c(C1=O)ccc(c2)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2208389
PubChem CID:   71454364
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002507] Homoisoflavonoids
        • [CHEMONTID:0002508] Homoisoflavans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO29935 Caesalpinia sappan Species Fabaceae Eukaryota n.a. heartwood n.a. PMID[19420770]
NPO29935 Caesalpinia sappan Species Fabaceae Eukaryota n.a. heartwood n.a. PMID[21800859]
NPO29935 Caesalpinia sappan Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[21800859]
NPO29935 Caesalpinia sappan Species Fabaceae Eukaryota heartwood n.a. n.a. PMID[23127886]
NPO29935 Caesalpinia sappan Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[23234407]
NPO29935 Caesalpinia sappan Species Fabaceae Eukaryota seeds Nanning, Guangxi Province, China 2013-APR PMID[26398312]
NPO29935 Caesalpinia sappan Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO29935 Caesalpinia sappan Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell Line RAW264.7 Mus musculus IC50 > 50000.0 nM PMID[575719]
NPT35 Others n.a. IC50 = 102560.0 nM PMID[575719]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC67876 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9801 High Similarity NPC55738
0.98 High Similarity NPC474638
0.9799 High Similarity NPC141212
0.9735 High Similarity NPC471515
0.9735 High Similarity NPC52530
0.9735 High Similarity NPC471479
0.9671 High Similarity NPC152904
0.9669 High Similarity NPC471500
0.9669 High Similarity NPC320825
0.9669 High Similarity NPC13858
0.9669 High Similarity NPC326037
0.9667 High Similarity NPC18727
0.9608 High Similarity NPC287328
0.9608 High Similarity NPC282009
0.9608 High Similarity NPC470183
0.9605 High Similarity NPC291508
0.9605 High Similarity NPC27337
0.9605 High Similarity NPC299520
0.9605 High Similarity NPC129684
0.96 High Similarity NPC219582
0.96 High Similarity NPC55205
0.96 High Similarity NPC302950
0.96 High Similarity NPC477231
0.96 High Similarity NPC472912
0.96 High Similarity NPC236637
0.96 High Similarity NPC257648
0.9548 High Similarity NPC472625
0.9545 High Similarity NPC471499
0.9545 High Similarity NPC173137
0.9545 High Similarity NPC308992
0.9542 High Similarity NPC22192
0.9539 High Similarity NPC250922
0.9539 High Similarity NPC472916
0.9539 High Similarity NPC278778
0.9539 High Similarity NPC291878
0.9539 High Similarity NPC303255
0.9539 High Similarity NPC265511
0.9539 High Similarity NPC35038
0.9539 High Similarity NPC195796
0.9536 High Similarity NPC236223
0.9536 High Similarity NPC325028
0.9536 High Similarity NPC246328
0.9536 High Similarity NPC270620
0.9536 High Similarity NPC78326
0.9536 High Similarity NPC256346
0.9536 High Similarity NPC469550
0.9536 High Similarity NPC179126
0.9536 High Similarity NPC27532
0.9533 High Similarity NPC200740
0.9533 High Similarity NPC125062
0.9533 High Similarity NPC31363
0.9533 High Similarity NPC54394
0.9533 High Similarity NPC252933
0.9487 High Similarity NPC224280
0.9487 High Similarity NPC234052
0.9487 High Similarity NPC62261
0.9484 High Similarity NPC474034
0.9484 High Similarity NPC472964
0.9484 High Similarity NPC474033
0.9481 High Similarity NPC470326
0.9481 High Similarity NPC118256
0.9481 High Similarity NPC474960
0.9481 High Similarity NPC192686
0.9481 High Similarity NPC119209
0.9481 High Similarity NPC472624
0.9481 High Similarity NPC472902
0.9481 High Similarity NPC263449
0.9477 High Similarity NPC472910
0.9477 High Similarity NPC52889
0.9477 High Similarity NPC474836
0.9477 High Similarity NPC48208
0.9477 High Similarity NPC472913
0.9477 High Similarity NPC472963
0.9477 High Similarity NPC96167
0.9477 High Similarity NPC472914
0.9477 High Similarity NPC99597
0.9477 High Similarity NPC162869
0.9477 High Similarity NPC156057
0.9477 High Similarity NPC245758
0.9477 High Similarity NPC472598
0.9477 High Similarity NPC222814
0.9477 High Similarity NPC474208
0.9477 High Similarity NPC472911
0.9477 High Similarity NPC210084
0.9477 High Similarity NPC475267
0.9477 High Similarity NPC474055
0.9474 High Similarity NPC31018
0.9474 High Similarity NPC117992
0.9474 High Similarity NPC230149
0.9474 High Similarity NPC2928
0.9474 High Similarity NPC234255
0.9474 High Similarity NPC255807
0.9474 High Similarity NPC45849
0.9474 High Similarity NPC200761
0.9474 High Similarity NPC57674
0.9474 High Similarity NPC470327
0.9474 High Similarity NPC256925
0.9474 High Similarity NPC168247
0.9474 High Similarity NPC152951
0.9474 High Similarity NPC477503
0.947 High Similarity NPC260491
0.947 High Similarity NPC240476
0.947 High Similarity NPC260979
0.947 High Similarity NPC9743
0.947 High Similarity NPC279989
0.947 High Similarity NPC36835
0.947 High Similarity NPC60972
0.947 High Similarity NPC39732
0.947 High Similarity NPC82325
0.947 High Similarity NPC246162
0.947 High Similarity NPC61506
0.9467 High Similarity NPC338131
0.9467 High Similarity NPC50728
0.9467 High Similarity NPC166753
0.9467 High Similarity NPC29231
0.9427 High Similarity NPC477517
0.9427 High Similarity NPC471213
0.9423 High Similarity NPC41301
0.9423 High Similarity NPC124038
0.9419 High Similarity NPC474038
0.9419 High Similarity NPC472632
0.9419 High Similarity NPC112418
0.9419 High Similarity NPC472634
0.9419 High Similarity NPC471210
0.9419 High Similarity NPC134783
0.9416 High Similarity NPC204879
0.9416 High Similarity NPC184755
0.9416 High Similarity NPC74178
0.9412 High Similarity NPC209614
0.9412 High Similarity NPC235165
0.9412 High Similarity NPC472626
0.9412 High Similarity NPC470328
0.9412 High Similarity NPC255106
0.9412 High Similarity NPC24640
0.9412 High Similarity NPC49824
0.9412 High Similarity NPC472455
0.9412 High Similarity NPC472907
0.9408 High Similarity NPC206238
0.9408 High Similarity NPC49402
0.9408 High Similarity NPC70433
0.9408 High Similarity NPC33051
0.9408 High Similarity NPC213896
0.9408 High Similarity NPC162351
0.9408 High Similarity NPC472905
0.9408 High Similarity NPC88645
0.9408 High Similarity NPC192083
0.9408 High Similarity NPC292214
0.9408 High Similarity NPC227337
0.9408 High Similarity NPC74924
0.9408 High Similarity NPC271779
0.9408 High Similarity NPC472915
0.9408 High Similarity NPC167091
0.9408 High Similarity NPC58382
0.9408 High Similarity NPC273462
0.9404 High Similarity NPC236769
0.9404 High Similarity NPC471229
0.9404 High Similarity NPC260895
0.9404 High Similarity NPC50403
0.9404 High Similarity NPC28274
0.9404 High Similarity NPC133953
0.94 High Similarity NPC137062
0.94 High Similarity NPC183950
0.94 High Similarity NPC183959
0.94 High Similarity NPC270465
0.94 High Similarity NPC159103
0.94 High Similarity NPC52005
0.94 High Similarity NPC87125
0.94 High Similarity NPC287101
0.94 High Similarity NPC177298
0.94 High Similarity NPC223579
0.94 High Similarity NPC1612
0.94 High Similarity NPC105512
0.94 High Similarity NPC48479
0.9396 High Similarity NPC472918
0.9396 High Similarity NPC95864
0.9363 High Similarity NPC36
0.9363 High Similarity NPC108433
0.9363 High Similarity NPC72787
0.9363 High Similarity NPC7688
0.9363 High Similarity NPC58223
0.9363 High Similarity NPC300053
0.9363 High Similarity NPC7154
0.9363 High Similarity NPC125039
0.9363 High Similarity NPC36916
0.9359 High Similarity NPC474162
0.9359 High Similarity NPC472635
0.9359 High Similarity NPC472448
0.9359 High Similarity NPC476247
0.9359 High Similarity NPC83922
0.9359 High Similarity NPC471745
0.9359 High Similarity NPC474150
0.9355 High Similarity NPC472631
0.9355 High Similarity NPC476980
0.9355 High Similarity NPC328102
0.9355 High Similarity NPC471744
0.9355 High Similarity NPC475784
0.9355 High Similarity NPC36217
0.9355 High Similarity NPC472630
0.9355 High Similarity NPC174953
0.9351 High Similarity NPC93376

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC67876 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.96 High Similarity NPD1934 Approved
0.9412 High Similarity NPD3882 Suspended
0.9408 High Similarity NPD2393 Clinical (unspecified phase)
0.9363 High Similarity NPD6166 Phase 2
0.9363 High Similarity NPD6168 Clinical (unspecified phase)
0.9363 High Similarity NPD6167 Clinical (unspecified phase)
0.9281 High Similarity NPD2801 Approved
0.92 High Similarity NPD1512 Approved
0.9097 High Similarity NPD3817 Phase 2
0.9067 High Similarity NPD1511 Approved
0.8896 High Similarity NPD7074 Phase 3
0.8889 High Similarity NPD3818 Discontinued
0.8882 High Similarity NPD4378 Clinical (unspecified phase)
0.8861 High Similarity NPD7075 Discontinued
0.8841 High Similarity NPD6797 Phase 2
0.8834 High Similarity NPD7054 Approved
0.8797 High Similarity NPD4868 Clinical (unspecified phase)
0.879 High Similarity NPD7096 Clinical (unspecified phase)
0.8788 High Similarity NPD7251 Discontinued
0.878 High Similarity NPD7472 Approved
0.8735 High Similarity NPD7808 Phase 3
0.8735 High Similarity NPD4338 Clinical (unspecified phase)
0.8733 High Similarity NPD1549 Phase 2
0.8718 High Similarity NPD4380 Phase 2
0.8693 High Similarity NPD6799 Approved
0.8667 High Similarity NPD1550 Clinical (unspecified phase)
0.8667 High Similarity NPD1552 Clinical (unspecified phase)
0.8634 High Similarity NPD5494 Approved
0.8625 High Similarity NPD4381 Clinical (unspecified phase)
0.8533 High Similarity NPD1510 Phase 2
0.8503 High Similarity NPD7993 Clinical (unspecified phase)
0.8491 Intermediate Similarity NPD6801 Discontinued
0.8481 Intermediate Similarity NPD6599 Discontinued
0.8477 Intermediate Similarity NPD2796 Approved
0.8438 Intermediate Similarity NPD7819 Suspended
0.8397 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8389 Intermediate Similarity NPD1240 Approved
0.8383 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD1465 Phase 2
0.8313 Intermediate Similarity NPD7411 Suspended
0.8303 Intermediate Similarity NPD6232 Discontinued
0.8278 Intermediate Similarity NPD1607 Approved
0.8274 Intermediate Similarity NPD5844 Phase 1
0.8272 Intermediate Similarity NPD5402 Approved
0.8272 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8267 Intermediate Similarity NPD943 Approved
0.8263 Intermediate Similarity NPD7473 Discontinued
0.8253 Intermediate Similarity NPD3926 Phase 2
0.8242 Intermediate Similarity NPD1247 Approved
0.8232 Intermediate Similarity NPD919 Approved
0.8176 Intermediate Similarity NPD5403 Approved
0.8146 Intermediate Similarity NPD1613 Approved
0.8146 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8133 Intermediate Similarity NPD6959 Discontinued
0.8129 Intermediate Similarity NPD6559 Discontinued
0.8121 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.8054 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.805 Intermediate Similarity NPD5401 Approved
0.7988 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7974 Intermediate Similarity NPD230 Phase 1
0.7952 Intermediate Similarity NPD3749 Approved
0.795 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7947 Intermediate Similarity NPD3027 Phase 3
0.7935 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7911 Intermediate Similarity NPD3750 Approved
0.7898 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD3751 Discontinued
0.7892 Intermediate Similarity NPD7768 Phase 2
0.7885 Intermediate Similarity NPD2935 Discontinued
0.7885 Intermediate Similarity NPD1551 Phase 2
0.7862 Intermediate Similarity NPD6190 Approved
0.7857 Intermediate Similarity NPD447 Suspended
0.7848 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7841 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7824 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7799 Intermediate Similarity NPD4628 Phase 3
0.7778 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD6100 Approved
0.7771 Intermediate Similarity NPD6099 Approved
0.7765 Intermediate Similarity NPD3787 Discontinued
0.7742 Intermediate Similarity NPD1933 Approved
0.7736 Intermediate Similarity NPD2800 Approved
0.7722 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7717 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7716 Intermediate Similarity NPD2534 Approved
0.7716 Intermediate Similarity NPD2533 Approved
0.7716 Intermediate Similarity NPD2532 Approved
0.7706 Intermediate Similarity NPD7199 Phase 2
0.7697 Intermediate Similarity NPD9494 Approved
0.7683 Intermediate Similarity NPD1653 Approved
0.7667 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD920 Approved
0.7611 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.761 Intermediate Similarity NPD2344 Approved
0.7595 Intermediate Similarity NPD3748 Approved
0.7588 Intermediate Similarity NPD6234 Discontinued
0.7578 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7578 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7557 Intermediate Similarity NPD5953 Discontinued
0.7543 Intermediate Similarity NPD7286 Phase 2
0.7533 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD4908 Phase 1
0.753 Intermediate Similarity NPD3226 Approved
0.7516 Intermediate Similarity NPD1243 Approved
0.7514 Intermediate Similarity NPD7685 Pre-registration
0.75 Intermediate Similarity NPD8434 Phase 2
0.75 Intermediate Similarity NPD2346 Discontinued
0.75 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD2799 Discontinued
0.7484 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7472 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD6651 Approved
0.7459 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7451 Intermediate Similarity NPD1203 Approved
0.7436 Intermediate Similarity NPD6798 Discontinued
0.7436 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7436 Intermediate Similarity NPD2313 Discontinued
0.7433 Intermediate Similarity NPD6779 Approved
0.7433 Intermediate Similarity NPD6780 Approved
0.7433 Intermediate Similarity NPD6781 Approved
0.7433 Intermediate Similarity NPD6782 Approved
0.7433 Intermediate Similarity NPD6776 Approved
0.7433 Intermediate Similarity NPD6777 Approved
0.7433 Intermediate Similarity NPD6778 Approved
0.7423 Intermediate Similarity NPD2309 Approved
0.7419 Intermediate Similarity NPD6832 Phase 2
0.7417 Intermediate Similarity NPD1610 Phase 2
0.7414 Intermediate Similarity NPD5242 Approved
0.7405 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD8150 Discontinued
0.7396 Intermediate Similarity NPD37 Approved
0.7386 Intermediate Similarity NPD7228 Approved
0.7375 Intermediate Similarity NPD7033 Discontinued
0.7371 Intermediate Similarity NPD2403 Approved
0.7368 Intermediate Similarity NPD4966 Approved
0.7368 Intermediate Similarity NPD4967 Phase 2
0.7368 Intermediate Similarity NPD4965 Approved
0.7333 Intermediate Similarity NPD8313 Approved
0.7333 Intermediate Similarity NPD7390 Discontinued
0.7333 Intermediate Similarity NPD8312 Approved
0.7317 Intermediate Similarity NPD2354 Approved
0.7316 Intermediate Similarity NPD7435 Discontinued
0.731 Intermediate Similarity NPD5353 Approved
0.7296 Intermediate Similarity NPD6355 Discontinued
0.7292 Intermediate Similarity NPD7584 Approved
0.729 Intermediate Similarity NPD2798 Approved
0.7289 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD6233 Phase 2
0.7267 Intermediate Similarity NPD1548 Phase 1
0.7267 Intermediate Similarity NPD4308 Phase 3
0.7261 Intermediate Similarity NPD4625 Phase 3
0.7258 Intermediate Similarity NPD4360 Phase 2
0.7258 Intermediate Similarity NPD4363 Phase 3
0.7257 Intermediate Similarity NPD5711 Approved
0.7257 Intermediate Similarity NPD5710 Approved
0.7255 Intermediate Similarity NPD9269 Phase 2
0.7255 Intermediate Similarity NPD9717 Approved
0.7235 Intermediate Similarity NPD6386 Approved
0.7235 Intermediate Similarity NPD6385 Approved
0.7233 Intermediate Similarity NPD4060 Phase 1
0.7225 Intermediate Similarity NPD7698 Approved
0.7225 Intermediate Similarity NPD7696 Phase 3
0.7225 Intermediate Similarity NPD7697 Approved
0.7215 Intermediate Similarity NPD3268 Approved
0.7212 Intermediate Similarity NPD3887 Approved
0.7208 Intermediate Similarity NPD4749 Approved
0.72 Intermediate Similarity NPD5536 Phase 2
0.7193 Intermediate Similarity NPD6844 Discontinued
0.7191 Intermediate Similarity NPD2163 Approved
0.7188 Intermediate Similarity NPD7871 Phase 2
0.7188 Intermediate Similarity NPD7870 Phase 2
0.7186 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7182 Intermediate Similarity NPD7549 Discontinued
0.7178 Intermediate Similarity NPD7266 Discontinued
0.7175 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD5019 Clinical (unspecified phase)
0.7166 Intermediate Similarity NPD6534 Approved
0.7166 Intermediate Similarity NPD6535 Approved
0.7165 Intermediate Similarity NPD7701 Phase 2
0.7152 Intermediate Similarity NPD7095 Approved
0.7143 Intermediate Similarity NPD1608 Approved
0.7143 Intermediate Similarity NPD5049 Phase 3
0.7135 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD2424 Discontinued
0.7134 Intermediate Similarity NPD2861 Phase 2
0.7134 Intermediate Similarity NPD3018 Phase 2
0.7128 Intermediate Similarity NPD8151 Discontinued
0.7126 Intermediate Similarity NPD4357 Discontinued
0.712 Intermediate Similarity NPD2494 Approved
0.712 Intermediate Similarity NPD2493 Approved
0.7118 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD7458 Discontinued
0.7115 Intermediate Similarity NPD2797 Approved
0.7107 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD411 Approved
0.7092 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7092 Intermediate Similarity NPD7874 Approved
0.7091 Intermediate Similarity NPD1652 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data